Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
Investigating primary prevention strategies against cardiovascular disease in people living with HIV.
View PublicationInvestigating primary prevention strategies against cardiovascular disease in people living with HIV.
View PublicationLooking at the treatment of porphyria cutanea tarda in a person living with HIV.
View PublicationExamining the global prevalence of chronic pain in women with HIV
View PublicationLooking at bone mineral density in women living with HIV.
View PublicationExamining the risk of hospitalization within 14 days of COVID-19 diagnosis among people living with HIV (PLWH) and HIV-negative individuals who had laboratory-confirmed SARS-CoV-2 infection.
View PublicationConsidering the prevalence of HPgV in a cohort of HCV/HIV co-infected patients undergoing treatment for HCV with direct acting antivirals (DAA) and investigate the effect of DAA therapy on HPgV infection.
View PublicationConsidering temporal changes in plasma proteins following SARS-CoV-2 infection and pre-infection proteomic markers associated with future COVID-19
View PublicationConsidering the effects of host factors and COVID-19 on the humoral repertoire in people living with HIV.
View PublicationConsidering the impact of COVID-19 on Two-Spirit, lesbian, gay, bisexual, transgender, and queer (2SLGBTQ+) populations in Canada
View PublicationConsidering the relationship between inflammasome activation and coronary plaque.
View Publication